| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 352 | 318 | 0 | 0 | 0 | 0 | 0 | 0 | 115.840 | 222.447 |
| Total Income - EUR | 352 | 318 | 0 | 0 | 0 | 0 | 0 | 0 | 115.842 | 226.659 |
| Total Expenses - EUR | 8.640 | 852 | 124 | 0 | 0 | 45 | 45 | 31 | 50.336 | 114.048 |
| Gross Profit/Loss - EUR | -8.288 | -534 | -124 | 0 | 0 | -45 | -45 | -31 | 65.506 | 112.611 |
| Net Profit/Loss - EUR | -8.288 | -534 | -124 | 0 | 0 | -45 | -45 | -31 | 64.348 | 106.152 |
| Employees | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
Check the financial reports for the company - Total Paliativ Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 192 | 190 | 187 | 184 | 180 | 0 | 0 | 0 | 331.142 | 364.090 |
| Current Assets | 425 | 656 | 873 | 396 | 389 | 387 | 292 | 293 | 18.221 | 44.510 |
| Inventories | 80 | 79 | 78 | 76 | 75 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 318 | 0 | 307 | 301 | 248 | 243 | 244 | 8.742 | 243 |
| Cash | 346 | 259 | 796 | 13 | 12 | 139 | 49 | 49 | 9.479 | 44.268 |
| Shareholders Funds | -8.243 | -8.692 | -7.875 | -8.389 | -8.226 | -7.710 | -7.583 | -7.638 | 56.733 | 106.200 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.860 | 9.539 | 8.935 | 8.968 | 8.795 | 8.097 | 7.875 | 7.931 | 292.630 | 302.401 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Total Paliativ Med Srl